Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 10—October 2013
Research

Antibody Responses against Pneumocystis jirovecii in Health Care Workers Over Time

Serena FongComments to Author , Kieran R. Daly, Renuka Tipirneni, Leah G. Jarlsberg, Kpandja Djawe, Judy V. Koch, Alexandra Swartzman, Brenna Roth, Peter D. Walzer, and Laurence Huang
Author affiliations: San Francisco General Hospital/University of California, San Francisco, San Francisco, California, USA (S. Fong, R. Tipirneni, L.G. Jarlsberg, A. Swartzman, B. Roth, L. Huang); Veterans Affairs Medical Center/University of Cincinnati, Cincinnati, Ohio, USA (K.R. Daly, K. Djawe, J.V. Koch, P.D. Walzer)

Main Article

Table 2

Antibody levels against Msg, San Francisco General Hospital staff, San Francisco, California, USA, 2007–2009*†

Antibody Occupation, estimated geometric mean (95% CI)
p value
Clinical, n = 396 Nonclinical, n = 80
MsgA 12.0 (11.1–12.9) 18.4 (17.1–19.9) 0.45
MsgB 4.9 (4.6–5.1) 6.7 (6.3–7.1) 0.56
MsgC1 38.4 (35.9–41.1) 19.8 (18.6–21.2) 0.004
MsgC3 77.1 (71.9–82.7) 52.9 (49.4–56.8) 0.09
MsgC8 46.0 (42.9–49.2) 27.6 (25.8–29.6) 0.02
MsgC9 34.6 (32.7–36.6) 27.0 (25.5–28.5) 0.17

*Msg, major surface glycoprotein.
†By occupation for all time points and for all participants, adjusted for age and immune disorder,

Main Article

Page created: September 16, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external